Loading
NYSEHealthcareMedical - Healthcare Information Services
Latest quote
$97.86
−$0.49 · -0.50%
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Previous close
$97.86
−$0.49 · -0.50%
Pre-market
$97.87
+$0.01 · +0.01%
Oct 8, 6:12 AM ET
Regular session · ET · Market data may be delayed.
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Day range
Current $97.86
52-week range
Current $97.86
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
62
Undervalued
Sentiment
45
Mixed
Risk
35
Moderate Risk
Momentum
63
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Day range
Current $97.86
52-week range
Current $97.86
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 587.86M USD | 390.4M USD | 292.73M USD |
| Cost of goods sold | 118.56M USD | 89.81M USD | 98.55M USD |
| Gross profit | 469.3M USD | 300.59M USD | 194.18M USD |
| Research and development | 368.14M USD | 100.84M USD | 110.06M USD |
| Selling, general, and administrative | 639.41M USD | 227.54M USD | 214.64M USD |
| Operating expenses | 1.02B USD | 332.5M USD | 324.69M USD |
| Depreciation and amortization | 5.13M USD | 5.95M USD | 5.63M USD |
| Operating income | −546.37M USD | −31.91M USD | −130.51M USD |
| Net income | −528.26M USD | −11.93M USD | −108.14M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$100.85
3.06% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI137.02M0.01%2.3T USD0.03%$381.03-0.40%
iShares Russell 2000 ETFIWM114.22M0.15%78.56B USD0.19%$277.7-1.29%
Vanguard Morningstar Small-Cap ETFVB98.86M0.05%185.3B USD0.03%$286.98-1.41%
Vanguard Morningstar Small-Cap Value ETFVBR62.83M0.09%68.2B USD0.05%$232.17-1.32%
iShares Russell 2000 Growth ETFIWO41.02M0.29%14.25B USD0.24%$355.37-1.43%
Vanguard Extended Market ETFVXF34.14M0.04%95.4B USD0.05%$233.49-1.56%
Schwab U.S. Small-Cap ETFSCHA30.42M0.14%22.01B USD0.03%$32.61-1.47%
Vanguard Russell 2000 ETFVTWO22.22M0.12%18B USD0.06%$112.21-1.26%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRiShares Russell 2000 Growth ETFIWOVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
